LDN-212854 T1900
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
LDN-212854, a novel BMP inhibitor, exhibits greater selectivity for BMP versus the TGF-_ type I receptors; possesses differences towards ALK2(IC50=1.3 nM) versus ALK1/3 compared to other inhibitors.
CAS nr:
1432597-26-6
Purity:
98%
Molecular Weight:
406,48
SMILES:
C1CN(CCN1)c1ccc(cc1)-c1cnc2c(cnn2c1)-c1cccc2ncccc12
Formula:
C25H22N6
Pathway:
Angiogenesis,Stem Cells,Tyrosine Kinase/Adaptors
Target:
ALK,TGF-beta/Smad,ALK
